Symphony Life Berhad Balans Gezondheid

Financiële gezondheid criteriumcontroles 4/6

Symphony Life Berhad heeft een totaal eigen vermogen van MYR914.3M en een totale schuld van MYR152.9M, wat de schuld-eigenvermogensverhouding op 16.7% brengt. De totale activa en totale passiva bedragen respectievelijk MYR1.2B en MYR287.8M. De EBIT Symphony Life Berhad is MYR6.9M waardoor de rentedekking 0.7 is. Het heeft contanten en kortetermijnbeleggingen van MYR34.2M.

Belangrijke informatie

16.7%

Verhouding schuld/eigen vermogen

RM 152.86m

Schuld

Rente dekkingsratio	0.7x
Contant	RM 34.16m
Aandelen	RM 914.31m
Totaal verplichtingen	RM 287.82m
Totaal activa	RM 1.20b

Recente financiële gezondheidsupdates

Recent updates

Symphony Life Berhad's (KLSE:SYMLIFE) 27% Price Boost Is Out Of Tune With Revenues

Mar 31

Is Symphony Life Berhad (KLSE:SYMLIFE) Using Too Much Debt?

Sep 29

Is Symphony Life Berhad (KLSE:SYMLIFE) Using Too Much Debt?

May 12

Estimating The Intrinsic Value Of Symphony Life Berhad (KLSE:SYMLIFE)

Mar 02

Is Symphony Life Berhad (KLSE:SYMLIFE) An Attractive Dividend Stock?

Feb 02

What Can We Make Of Symphony Life Berhad's (KLSE:SYMLIFE) CEO Compensation?

Jan 13

Symphony Life Berhad (KLSE:SYMLIFE) Has A Somewhat Strained Balance Sheet

Dec 21

Update: Symphony Life Berhad (KLSE:SYMLIFE) Stock Gained 63% In The Last Year

Dec 02

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( MYR312.0M ) SYMLIFE } overtreffen de korte termijn passiva ( MYR163.7M ).

Langlopende schulden: De kortetermijnactiva SYMLIFE ( MYR312.0M ) overtreffen de langetermijnschulden ( MYR124.1M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 13% ) SYMLIFE wordt als voldoende beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van SYMLIFE is de afgelopen 5 jaar gedaald van 54.6% naar 16.7%.

Schuldendekking: De schuld van SYMLIFE wordt niet goed gedekt door de operationele kasstroom ( 0.02% ).

Rentedekking: De rentebetalingen van SYMLIFE op haar schulden worden niet goed gedekt door EBIT ( 0.7 x dekking).

Symphony Life Berhad Balans Gezondheid

Financiële gezondheid criteriumcontroles 4/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Is Symphony Life Berhad (KLSE:SYMLIFE) Using Too Much Debt?

Is Symphony Life Berhad (KLSE:SYMLIFE) Using Too Much Debt?

Symphony Life Berhad (KLSE:SYMLIFE) Has A Somewhat Strained Balance Sheet

Recent updates

First quarter 2025 earnings released: RM0.001 loss per share (vs RM0.004 loss in 1Q 2024)

Now 25% undervalued after recent price drop

Now 20% undervalued after recent price drop

Full year 2024 earnings released: RM0.012 loss per share (vs RM0.11 loss in FY 2023)

High number of new and inexperienced directors

Symphony Life Berhad, Annual General Meeting, Sep 11, 2024

Symphony Life Berhad, Annual General Meeting, Sep 11, 2024

Symphony Life Berhad Appoints Miss Bianca Ng Sze Cay as Independent and Non-Executive Director, Date of Change 15 July 2024

Full year 2024 earnings released: RM0.012 loss per share (vs RM0.11 loss in FY 2023)

Symphony Life Berhad Announces Resignation of Wendy Phan Su Ann as Independent and Non Executive Director

Symphony Life Berhad's (KLSE:SYMLIFE) 27% Price Boost Is Out Of Tune With Revenues

Third quarter 2024 earnings released: EPS: RM0.001 (vs RM0 in 3Q 2023)

High number of new directors

Symphony Life Berhad Appoints Tan Yu Wei as Independent and Non Executive Director

Symphony Life Berhad Appoints DATO JASMY BIN ISMAIL as Independent and Non Executive Member of Audit Committee

Second quarter 2024 earnings released: EPS: RM0.002 (vs RM0.009 loss in 2Q 2023)

Symphony Life Berhad Announces Redesignation of Tan Sri Dato' Seri Tan King Tai @ Tan Khoon Hai from Executive Chairman to Non Executive Chairman, Effective 1 October 2023

First quarter 2024 earnings released: RM0.003 loss per share (vs RM0.007 loss in 1Q 2023)

Full year 2023 earnings released: RM0.11 loss per share (vs RM0.06 profit in FY 2022)

Symphony Life Berhad, Annual General Meeting, Sep 06, 2023

Full year 2023 earnings released: RM0.11 loss per share (vs RM0.06 profit in FY 2022)

Third quarter 2023 earnings released: EPS: RM0.001 (vs RM0.097 in 3Q 2022)

Symphony Life Berhad Announces the Resignation of Mr. Teo Chiah Chyi as Non-Independent Director, Effective 01 January 2023

SYMPHONY LIFE BERHAD Appoints TAN SIK EEK as Executive Director, Effective from December 27, 2022

Second quarter 2023 earnings released: RM0.009 loss per share (vs RM0.016 loss in 2Q 2022)

High number of new directors

High number of new directors

Full year 2022 earnings released: EPS: RM0.06 (vs RM0.11 in FY 2021)

Symphony Life Berhad, Annual General Meeting, Sep 07, 2022

Full year 2022 earnings released: EPS: RM0.059 (vs RM0.11 in FY 2021)

Symphony Life Berhad Appoints Wendy Phan Su Ann as Independent and Non Executive Member of Remuneration Committee, Effective 31 March 2022

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

High number of new directors

Second quarter 2022 earnings: Revenues and EPS in line with analyst expectations

High number of new directors

High number of new directors

Is Symphony Life Berhad (KLSE:SYMLIFE) Using Too Much Debt?

Group Chief Financial Officer Ying Ng has left the company

High number of new and inexperienced directors

High number of new and inexperienced directors

High number of new and inexperienced directors

Independent Non Executive Director Chee Loi has left the company

Full year 2021 earnings released: EPS RM0.11 (vs RM0.12 in FY 2020)

Muar Ban Lee Group Berhad (KLSE:MBL) completed the acquisition of 10.6% stake in Symphony Life Berhad (KLSE:SYMLIFE) from Gajahrimau Capital Sdn. Bhd.

Upcoming dividend of RM0.02 per share

Full year 2021 earnings released: EPS RM0.11 (vs RM0.12 in FY 2020)

Independent & Non-Executive Director has left the company

Is Symphony Life Berhad (KLSE:SYMLIFE) Using Too Much Debt?

Non-Independent Executive Chairman & CEO Mohamed Bin Yahya has left the company

Independent & Non-Executive Director has left the company

Senior Independent Non-Executive Director has left the company

New 90-day high: RM0.64

Estimating The Intrinsic Value Of Symphony Life Berhad (KLSE:SYMLIFE)

Third quarter 2021 earnings released: EPS RM0.032 (vs RM0.065 in 3Q 2020)

Is Symphony Life Berhad (KLSE:SYMLIFE) An Attractive Dividend Stock?

What Can We Make Of Symphony Life Berhad's (KLSE:SYMLIFE) CEO Compensation?

New 90-day low: RM0.53

Symphony Life Berhad (KLSE:SYMLIFE) Has A Somewhat Strained Balance Sheet

Update: Symphony Life Berhad (KLSE:SYMLIFE) Stock Gained 63% In The Last Year

Second quarter 2021 earnings released: EPS RM0.04

New 90-day high - RM0.68

First quarter earnings released

Upcoming Dividend of RM0.02 Per Share

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven